ABX.TO (ABX.TO)

$90.3B
Market Cap
13.4
P/E Ratio
1.00
Beta
4.27%
Dividend Yield
Piotroski 9/9Altman Z 4.5 SafeBeneish M -3.01 CleanROIC−WACC +4.4%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 9/9, Altman Z 4.5 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits exceptional fundamental quality, characterized by a robust ROIC-WACC spread of +4.4% that signals strong value creation relative to the cost of capital. This economic moat is primarily driven by an impressive net margin expansion to 29.4%, which more than offsets modest asset turnover at 0.33x and moderate leverage via an equity multiplier of 1.44x, resulting in a DuPont-decomposed ROE of 13.9%. Financial integrity metrics further validate this profile; the perfect Piotroski F-Score of 9/9 indicates robust financial health across nine dimensions, while the Altman Z-Score of 4.5 and Beneish M-Score of -3.01 suggest a very low probability of bankruptcy and minimal earnings manipulation risk respectively.

Valuation metrics present a compelling divergence between current pricing and intrinsic value estimates. Trading at a P/E multiple of 13.4x, the stock appears significantly discounted relative to its trajectory given revenue growth accelerating at 31.2% YoY and gross margins holding steady above 50%. A DCF analysis anchors fair value at $75, implying that current market pricing may be conservative if the underlying assumptions regarding future cash flow generation hold true. This setup suggests the market has not yet fully priced in the sustainability of such high growth rates combined with superior profitability ratios.

While specific sector benchmarks and historical multiple comparisons are unavailable to contextualize the 13.4x P/E further, the convergence of aggressive top-line expansion, expansive margins, and pristine financial scores creates a favorable risk-reward asymmetry absent typical distress signals or earnings opacity concerns inherent in many high-growth peers.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →8.6%10.6%12.6%
2%$90$68$54
3%$104$75$58
4%$123$84$64

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=10.7%, terminal growth 3%. Fair value $75 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

9/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
4.5
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-3.01
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

51.3%
Gross Margin
29.4%
Net Margin
15.1%
ROIC
10.7%
WACC
ROIC − WACC Spread: +4.4%— Positive spread.
+31.2%
Revenue Growth (YoY)
+132.9%
Earnings Growth (YoY)
3.9B
Free Cash Flow
23%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

29.4%
Net Profit Margin
NI ÷ Revenue
×
0.33x
Asset Turnover
Revenue ÷ Assets
×
1.44x
Equity Multiplier
Assets ÷ Equity
=
13.9%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

0.44x
Debt / Equity
2.92x
Current Ratio
25.6x
Interest Coverage
-0.1x
Net Debt / EBITDA
4.36%
FCF Yield
11.1B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.30
Act: $0.35
+17.6%
Q3
✓ Beat
Est: $0.46
Act: $0.47
+1.3%
Q2
✗ Miss
Est: $0.61
Act: $0.58
-5.0%
Q1
✓ Beat
Est: $0.88
Act: $1.04
+18.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

8.8
Forward P/E
PEG Ratio
2.47
Price/Book
7M
Avg Volume
$74.00
52W High
$24.28
52W Low
52W Range Position

ABX.TO Capital Efficiency

How efficiently does ABX.TO convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$3.9B
EBITDA
$11.1B
FCF Conversion
35%
Reinvestment Rate
65%
35% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
15.1%
ROIC − WACC Spread
4.4%

ABX.TO converts 35% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 65% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 4.4% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare ABX.TO to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.